Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients.
Redox Biol
; 60: 102599, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36640725
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Renal Insufficiency, Chronic
/
Head and Neck Neoplasms
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Redox Biol
Year:
2023
Document type:
Article